Ascendis Investor Alert - Ascendis Pharma (NASDAQ:ASND)

Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Ascendis To Contact Him Directly To Discuss Their OptionsNew York, New York--(Newsfile Corp. - June 14,

Related Keywords

New York ,United States ,Pennsylvania ,Georgia ,California ,Ascendis Pharma ,Faruqi ,Josh Wilson ,James Josh Wilson ,Company New Drug Application ,Us Food Drug Administration ,York Newsfile Corp ,Securities Litigation Partner James ,Drug Administration ,New Drug Application ,Ascendi American Depository Shares ,